Article info

Download PDFPDF

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB

Authors

  1. Correspondence to Professor Kalipso Chalkidou; kchalkidou{at}cgdev.org
View Full Text

Citation

Chalkidou K, Towse A, Silverman R, et al
Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB

Publication history

  • Received October 18, 2019
  • Revised February 26, 2020
  • Accepted February 28, 2020
  • First published April 23, 2020.
Online issue publication 
April 23, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.